Rab Prinjha

Director/Board Member presso Padlock Therapeutics, Inc.

Health Technology

Consumer Services

Profilo

Rab Prinjha is currently a Director at Padlock Therapeutics, Inc. He previously worked as the Head of Epigenetics Discovery Performance Unit at GSK Plc.
He obtained a doctorate degree from University College London.

Posizioni attive di Rab Prinjha

Società	Posizione	Inizio
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Director/Board Member	-

Tutte le posizioni attive di Rab Prinjha

Precedenti posizioni note di Rab Prinjha

Società	Posizione	Fine
GSK PLC	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Rab Prinjha

Formazione di Rab Prinjha

University College London

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Rab Prinjha

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
GSK PLC	Health Technology

Aziende private	1
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Health Technology